No obstante, se recomienda un control frecuente de la INR al inicio del tratamiento con semaglutida en pacientes tratados con warfarina u otros derivados de la cumarina
Some botanical extracts are claimed to influence fat oxidation or insulin sensitivity
DPP-4 inhibitors are also used therapeutically to enhance endogenous GLP-1 activity, but only for glycemic control, as they are weight-neutral
The results were consistent: Trunk fat reduction: Tesamorelin-treated patients showed statistically significant reductions in trunk fat versus placebo at 26 weeks.[1] VAT reduction: Using cross-sectional CT imaging, tesamorelin produced approximately 1520% reductions in visceral adipose tissue compared to placebo.[1,2] Triglyceride improvement: Alongside fat reduction, tesamorelin improved triglyceride levels a key marker in metabolic syndrome.[2] Tesamorelin IGF-1 elevation: Treatment reliably elevated IGF-1 levels toward age-appropriate norms, confirming successful GH-axis stimulation.[1] These reductions occurred without dietary caloric restriction being mandated
Both peptides are actively researched for their purported abilities to promote healing in various tissues and organs
Recurrent yeast infections despite good glycaemic control warrant GP review and possible further investigation of diabetes management
